Subtype

Ovarian Neoplasm

Non-malignant746 active trials5 approved drugs94 evidence items

NCIt: C4984
MeSH: D010051

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (174)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 101–125 of 174 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy in ovarian cancer: A systematic review and network meta-analysis.
Yang Liu, Wenrui Huang, Zhongkun Guo · J Ethnopharmacol · Sep 2, 2026 · PMID 42685937 · candidate dictionary pubmed
Xanthomicrol shifts the ERα/ERβ balance and promotes a less aggressive phenotype in SKOV‑3 ovarian cancer cells.
Isis Santos, Gabriel Gutiérrez-Ospina, Adelina Jiménez-Arellanes et al. · Nat Prod Res · Sep 2, 2026 · PMID 42685347 · candidate dictionary pubmed
Investigating the phytochemical composition of Curcuma longa, Azadirachta indica, and Asparagus racemosus using network pharmacology and molecular docking approaches for ovarian cancer therapy.
Seneha Santoshi, Aastha Tanwar, Riddhi Bahri et al. · Z Naturforsch C J Biosci · Sep 2, 2026 · PMID 42677485 · candidate dictionary pubmed
VISTA+ Neutrophils Contribute to Platinum Resistance by Suppressing CD8+ T Cells in High-Grade Serous Ovarian Cancer.
Chuying Huo, Xibo Zhao, Dongdong Ye et al. · Cancer Immunol Res · Sep 2, 2026 · PMID 42390478 · candidate dictionary pubmed
PRMT5 Inhibition by SCR-6920 Downregulates HIF-1α and Exhibits Synergistic Antitumor Activity with Bevacizumab in Ovarian Cancer.
Guimei Yang, Huixia Dou, Liting Xue et al. · Mol Cancer Ther · Sep 2, 2026 · PMID 42012942 · candidate dictionary pubmed
Diagnostic significance of cancer antigen 125/carcinoembryonic antigen ratio combined with IOTA-ADNEX model in discriminating between primary ovarian cancer and ovarian metastases.
Yaoqin Wang, Qianyi Zhang, Shixin Huang et al. · Quant Imaging Med Surg · Sep 1, 2026 · PMID 42701482

· candidate dictionary

pubmed

Altered ANG/TIE gene expression in advanced ovarian cancer is not accompanied by disproportionate body water accumulation relative to perioperative fluid balance.

Sarah Reifenhaeuser, Katrin Stein, Stilla Frede et al. · Sci Rep · Sep 1, 2026 · PMID 42680803 · candidate dictionary pubmed

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells.

Takahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi et al. · Cancer Rep (Hoboken) · Sep 1, 2026 · PMID 42702875 · candidate dictionary pubmed

A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.

Nihel Ammous-Boukhris, Rania Abdelmaksoud-Dammak, Ameni Feki et al. · Cancer Rep (Hoboken) · Sep 1, 2026 · PMID 42693633 · candidate dictionary pubmed

Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline MSH6 Variant: A Case Report.

Tomomi Yokozawa, Sayako Nakagawa, Yukio Suzuki et al. · Clin Case Rep · Sep 1, 2026 · PMID 42683025 · candidate dictionary pubmed

Small Extracellular Vesicle and Total Lipid Profiles Provide a Diagnostic Advantage Over CA-125 Across Ovarian Cancer Subtypes.

Shikha Rani, Dominic Guanzon, Andrew Lai et al. · J Extracell Vesicles · Sep 1, 2026 · PMID 42680694 · candidate dictionary pubmed

Outcomes and Long-term Follow-up of Epithelial Ovarian Cancer: Experience from the Lead Cancer Center of Pakistan.

Jamshed Ali, Mahnoor Raza, Muhammad Umer Khayyam Azam et al. · J Cancer Allied Spec · Mar 1, 2026 · PMID 42683210 · candidate dictionary pubmed

Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in BRCA1/2-proficient ovarian cancer.

Ou Deng, Thales Da Costa Nepomuceno, Bin Fang et al. · PLoS One · Jan 1, 2026 · PMID 42685115 · candidate dictionary pubmed

Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy.

Weranga Rajapaksha, Preethi Eldi, Todd A Gillam et al. · Int J Nanomedicine · Jan 1, 2026 · PMID 42732377 · candidate dictionary pubmed

Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Multicenter Real-World Study.

Xingyu Liu, Yiyang Shen, Yingjun Zhao et al. · Int J Womens Health · Jan 1, 2026 · PMID 42733847 · candidate dictionary pubmed

BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line.

Hala Khazem, Ravid Solomon Zemler, Liron Vardi David et al. · PLoS One · Jan 1, 2026 · PMID 42789557 · candidate dictionary pubmed

DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.

· Histopathology · 2016 · PMID 26033501 · validated civic_curation pubmed

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

· N Engl J Med · 2018 · PMID 30345884 · validated civic_curation pubmed

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.

· Gynecol Oncol · 2017 · PMID 28882436 · validated civic_curation pubmed

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

· N Engl J Med · 2016 · PMID 27717299 · validated civic_curation pubmed

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

· Nat Genet · 2014 · PMID 24658004 · validated cbioportal_study pubmed

Advanced ovarian cancer: what should be the standard of care?

· J Gynecol Oncol · 2013 · PMID 23346317 · validated civic_curation pubmed

Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer.

· Cancer · 2010 · PMID 20336784 · validated civic_curation pubmed

The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.

· Mod Pathol · 2010 · PMID 20693978 · validated civic_curation pubmed

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

· Clin Cancer Res · 2001 · PMID 11595686 · validated civic_curation pubmed